ALXO Q1 2020 Earnings — ALX Oncology Holdings Inc. Revenue & Financial Results | Market Cap Arena

ALXOALX Oncology Holdings Inc.

$113M

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$655,000-36.5% YoY

Gross Profit

$59,0009.0% margin

Operating Income

-$5M-800.3% margin

Net Income

-$5M-832.7% margin

EPS (Diluted)

$-0.16

QoQ Revenue Growth

-46.0%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$151,000

Balance Sheet

Total Assets

$108M

Total Liabilities

$9M

Stockholders' Equity

$99M

Cash & Equivalents

$105M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$655,000	$1M	-36.5%
Gross Profit	$59,000	$94,000	-37.2%
Operating Income	-$5M	-$4M	-24.0%
Net Income	-$5M	-$4M	-28.7%